Image
a close up of a sign
Advertisement
02/03/2022

Aurobindo obtains FDA approval for generic Colcrys

Colchicine tablets have a market value of $111 million for the 12 months ending November 2021, according to IQVIA.
Sandra Levy
Senior Editor
Sandra Levy profile picture

Aurobindo has received the Food and Drug Administration’s stamp of approval for Colchicine tablets.

The product is the generic of Takeda’s Colcrys.

[Read more: Aurobindo obtains FDA OK for generic Lioresal]

The medication is indicated in adults and children 4 years old or older for treatment of familial Mediterranean fever.

Colchicine tablets have a market value of $111 million for the 12 months ending November 2021, according to IQVIA.

[Read more: Aurobindo obtains FDA nod for generic Tricor]

    Advertisement
    Advertisement